Objective: A number of cervical smears may exhibit unequivocal low-grade squamous intraepithelial lesions (LSIL) in association with atypical cells cytomorphologically suspicious, but not sufficient to be interpreted as high-grade squamous intraepithelial lesions (HSIL). These lesions are presently called LSIL, atypical squamous cells cannot exclude HSIL (LSIL/ASC-H). Previous studies have shown that LSIL/ASC-H and ASC-H are both equivocal for HSIL and have a high risk of underlying HSIL. However, in researching the literature only two studies were found which rendered the results as cervical intraepithelial neoplasia (CIN) 2 and CIN3 separately. The purpose of this study was to compare the distribution of biopsy results for CIN2 and CIN3 in patients with ASC-H, HSIL, and LSIL/ASC-H. Study Design: Between January 2005 and December 2011, cervicovaginal smears (98,594) with a diagnosis of ASC-H, LSIL, LSIL/ASC-H, or HSIL were re-evaluated to determine the prevalence of future lesion development. Results: A total of 252 patients who had histologic follow-up within a year were selected. Among these, LSIL/ASC-H (31.7%) had the highest prevalence of CIN2 between LSIL (9.3%), ASC-H (10%), and HSIL (16%). All differences were statistically significant. Conclusion: Because of the high predictive value of CIN2, LSIL/ASC-H may have further importance, especially in women of different age groups.

Keywords:
Cervical intraepithelial neoplasia, Low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion, Bethesda system, Cervical cytology
1.
Owens CL, Moats DR, Burroughs FH, Gustafson KS: ‘Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion' is a distinct cytologic category: histologic outcomes and HPV prevalence. Am J Clin Pathol 2007;128:398-403.
2.
Kır G, Cetiner H, Gurbuz A, Karateke A: Reporting of ‘LSIL with ASC-H' on cervicovaginal smears: is it a valid category to predict cases with HSIL follow-up? Eur J Gynecol Oncol 2004;25:462-464.
3.
Kaygusuz EI, Cetiner H, Sahin D: LSIL/ASC-H(LSIL-H) in cervicovaginal smear: histopathological outcomes and clinical significance. Turk Patoloji Derg 2011;27:46-50.
4.
Hunter C, Duggan MA, Duan Q, Power P, Gregoire J, Nation J: Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H. Cytopathology 2009;20:17-26.
5.
Sidham BS, Kumar N, Narayan R, Brotzman GL: Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on Surepath specimens with review of literature. Cytojournal 2007;4:7.
6.
Difurio MJ, Mailhiot T, Sundborg MJ, Nauschuetz KK: Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H. Diagn Cytopathol 2010, 38:313-317.
7.
Elsheikh TM, Kirkpatrick JL, Wu HH: The significance of ‘low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion' as a distinct squamous abnormality category in Papanicolaou tests. Cancer 2006,108:277-281.
8.
Finkelstein A, Bajor-Dattilo EB, Yang MC, Szeto O, Zhou F, Elgert P, Das K: The utility of ‘low-grade intraepithelial lesion, cannot exclude high-grade' diagnosis: a single institution's experience. Acta Cytol 2012;56:383-387.
9.
Alsharif M, Kjeldahl K, Curran C, Miller S, Gulbahce HE, Pambuccian SE: Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion. Cancer Cytopathol 2009;117:92-100.
10.
Solomon D, Davey D, Kurman R, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
11.
Solomon D, Nayar R: The Bethesda System for Reporting Cervical Cytology: Definition, Criteria and Explanatory Notes ed 2. New York, Springer, 2004.
12.
Nasser SM, Cibas ES, Crum CP, Faquin WC: The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion. Cancer Cytopathol 2003;99:272-276.
13.
Power P, Gregoire J, Duggan M, Nation J: Low-grade Pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia. J Obstet Gynaecol Can 2006;28:884-887.
14.
Wright TC, Ronnett BM, Kurman RJ, Ferency A: Precancerous lesions of the cervix; in Kurman RJ, Ellenson LH, Ronnett BM (eds): Blaustein's Pathology of the Female Genital Tract, ed 6. New York, Springer, 2011, pp 193-252.
15.
Mitchell MF, Tortelero-Luna G, Wright T, Sarkar A, Richards-Kortum R, Hong WK, Schottenfeld D: Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 1996; 21:17-25.
16.
Castle PE, Schiffman M, Wheeler CM, Solomon D: Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18-25.
17.
McAllum B, Sykes PH, Sadler L, Macnab H, Simcock BJ, Mekhail AK: Is the treatment of CIN2 always necessary in women under 25 years old? Am J Obstet Gynecol 2011;205:478.e1-7.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.